Janet Napolitano and Renaissance Technologies filed reports regarding buying and selling shares of Vir Biotechnology stock with the SEC.

The entities involved

• VIR Biotechnology →

  biotech company

  • Financial firms, including RBC, Morgan Stanley, and TD Cowen, issued rating and holding updates on Vir Biotechnology.12:33
  • Raymond James Financial reaffirmed a strong-buy rating and Morgan Stanley set a $25.00 price objective for VIR Biotechnology.Fri 20:26
• Renaissance Technologies →

  American hedge fund firm

  • Renaissance Technologies, a hedge fund, has raised holdings in Forafric Global while operating in Morocco and distributing staple foods in Africa.04:31
  • Renaissance Technologies grew its stake in Cosmos Health on November 1, 2026.04:30
• SEC →

  Slovak company

  • Mangoceuticals, a Nasdaq-listed company, filed an offering statement with the SEC and partnered with T7X for tokenized stock issuance.14:24
  • MSCI index rules may affect Bitcoin companies, while warnings caused stock market crashes in Turkey and Indonesia.13:32

Related events

• Post Holdings disclosed a stock sale in a legal filing with the Securities and Exchange Commission.Sep 4
• InnovAge Holding Corp. stock is traded on Nasdaq, and large shareholders must disclose transactions to the SEC.Oct 23
• A director of Immunome, Inc. sold company stock on July 2, 2026, disclosing the transaction to the SEC.Jul 3
• Patricia Gallup, Chairman of PC Connection, Inc., sold company stock shares and disclosed the transaction to the SEC.Oct 23
• Director Lisa Jamieson sold shares of Forestar Group stock and disclosed the transaction to the SEC.Sat 00:53